ChiCTR1900026244
尚未开始
/
/
/
2019-09-28
/
/
乳腺癌
乳腺癌生存者自我管理應用程式的隨機對照試驗
Breast Cancer App protocol: a randomized controlled trial to evaluate a self-management app for breast cancer survivors
1) to examine whether there is the difference in the health literacy, problem solving skills, readiness of change, self-efficacy, self-management skill, and health-related quality of life between the intervention group and the control group; 2) to examine the usability of this self-management app versus a general health app.
随机平行对照
探索性研究/预试验
SPSS (IBM SPSS Statistics Version 25) will be used to generate the random sequence for group allocation.
Not addressed
Departmental research fund
/
244
/
2020-01-01
2021-06-30
/
1) female; 2) breast cancer survivors; 3) Cancer stages I to III; 4) completion of primary treatment within one year or longer; 5) aged 18 to 65 years; 6) acceptable literacy level (e.g. able to read, and write Chinese); 7) agree for checking of usage log of mobile app; 8) able to provide informed consent.；
请登录查看1) BCS diagnosed with severe mental illnesses; 2) Diagnosis of another cancer type rather than breast cancer; 3) has already participated in other clinical trial; 4) has been used other self-management app to manage the breast cancer.；
请登录查看香港理工大學康復科學系
/
求实药社2026-03-05
生物制品圈2026-03-05
医药观澜2026-03-05
医药观澜2026-03-05
河北省干细胞中心2026-03-05
生物制药小编2026-03-05
一度医药2026-03-05
炎明生物Pyrotech2026-03-05
药明康德2026-03-05
疑夕随笔2026-03-04
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
川公网安备51019002008863号
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
“坚决打赢禁毒人民战争”专栏 法律法规 | 美、墨、欧盟管制品种
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
